Furthermore, implementing preventative strategies allows the oncology team to factor in CV risks when selecting cancer treatments, educate patients about their risks, tailor CV surveillance and follow-up strategies, and refer high-risk patients to cardio-oncology services.2
The risk of cancer treatment-related CV adverse events (AEs) vary based on factors such as cancer type, stage, anti-cancer agents, doses, and underlying comorbidities.2
The effect of hormone therapy on the CV system
Current treatment options for patients living with PCa include surgery, radiotherapy...
